TidalSense
Natalie Douglas possesses extensive leadership experience across multiple organizations in the healthcare and pharmaceutical sectors. In current roles, Natalie serves as Chairman of the Board at Entia Ltd and TidalSense, and holds the position of CEO and Pharmaceutical Services Med Tech Advisor at Lucidity LLC. Other key contributions include serving as an Investor and Strategic Advisor at Ceek Women's Health, and as an Advisor on the board of directors at Vitaccess. Previously, Natalie was Chairman of the Board at Global Pricing Innovations and founded RealiTi Health. A former Vice Chair of Global Genes and CEO of Healthcare at Home Ltd, Natalie played a pivotal role in steering one of Europe's leading clinical homecare providers. Educational achievements include participation in programs at Harvard Business School Online and a Master of Arts in International Marketing from Middlesex University.
This person is not in any teams
This person is not in any offices
TidalSense
TidalSense, formerly Cambridge Respiratory Innovations, is a venture-backed respiratory technology company headquartered in Cambridge UK. TidalSense builds AI-driven diagnostic and monitoring solutions for respiratory medicine built on the foundation of the company's novel patented sensor technology, N-Tidal, which provides unprecedented insight into lung physiology through high accuracy, rapid sampled CO2, unlike anything seen before in clinical medicine.